Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative Infections

Background: Emerging data suggest that more aggressive beta-lactam PK/PD targets could minimize the occurrence of microbiological failure and/or resistance development. This study aims to assess whether a PK/PD target threshold of continuous infusion (CI) beta-lactams may be useful in preventing mic...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Milo Gatti, Pier Giorgio Cojutti, Renato Pascale, Tommaso Tonetti, Cristiana Laici, Alessio Dell’Olio, Antonio Siniscalchi, Maddalena Giannella, Pierluigi Viale, Federico Pea
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	PK/PD target attainment beta-lactams continuous infusion critically ill patients microbiological failure resistance development Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/03de6b031cb54ca19992da7872528a0a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative Infections

Ejemplares similares